The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.

Theodora C. van Tilborg*, Marinus J.C. Eijkemans, Joop S.E. Laven, Carolien A.M. Koks, Jan Peter de Bruin, Gabrielle J. Scheffer, Ron J.T. van Golde, Kathrin Fleischer, Annemieke Hoek, Annemiek W. Nap, Walter K.H. Kuchenbecker, Petra A. Manger, Egbert A. Brinkhuis, Arne M. van Heusden, Alexander V. Sluijmer, Arie Verhoeff, Marcel H.A. van Hooff, Jaap Friederich, Jesper M.J. Smeenk, Janet KweeHarold R. Verhoeve, Cornelis B. Lambalk, Frans M. Helmerhorst, Fulco van der Veen, Ben Willem J. Mol, Helen L. Torrance, Frank J.M. Broekmans

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences